Tc-99(m)-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: A comparison with mammography and histopathological diagnosis
N. Arslan et al., Tc-99(m)-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: A comparison with mammography and histopathological diagnosis, NUCL MED C, 20(4), 1999, pp. 317-325
The aim of this prospective study was to determine the diagnostic value of
prone lateral Tc-99(m)-MIBI scintimammography in the detection of primary b
reast cancer and axillary lymph node involvement in patients with breast le
sions. We evaluated 83 palpable and 22 non-palpable lesions in 77 consecuti
ve patients with a clinically palpable mass and/or suspicious mammographic
finding. Early and late scintimammograms were performed after the intraveno
us injection of 740 MBq Tc-99(m)-MIBI. The overall sensitivity of both scin
timammography and mammography in the detection of primary breast cancer was
94%. The overall specificity was 84% and 56% for scintimammography and mam
mography respectively. In the patients with palpable masses, the sensitivit
y of scintimammography was 97% and the specificity was 84%; in those with n
on-palpable masses, the sensitivity was 35% and the specificity 100%. For t
he detection of axillary lymph node involvement, the sensitivity and specif
icity of scintimammography were 68% and 93% respectively. However, conventi
onal mammography showed 37% sensitivity and 86% specificity. In conclusion,
scintimammography is an accurate and clinically valuable tool for evaluati
ng palpable and non-palpable breast abnormalities. In addition to its high
sensitivity, it improves the specificity of mammography both in the evaluat
ion of breast masses and in the detection of axillary involvement. ((C) 199
9 Lippincott Williams & Wilkins).